Showing results (161-170 of 262) with videos related to

Sort By:
Pageof 27
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 29, 2006
Progressive pulmonary sarcoidosis--a fibroproliferative process potentially triggered by EGR-1 and IL-6Michel P Bihl, Kirsten Laule-Kilian, Lukas Bubendorf, et al.
Thorax|November 5, 2015
Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert GroupManfred Dietel, Lukas Bubendorf, Anne-Marie C Dingemans, et al.
The Journal of Pathology|October 24, 2018
Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow-sorting approachThomas Lorber, Noemi Andor, Tanja Dietsche, et al.
Cell Death & Disease|July 13, 2019
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation studyIlaria Alborelli, Daniele Generali, Philip Jermann, et al.
Endocrine-Related Cancer|March 18, 2010
Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivoLei Gu, Paraskevi Vogiatzi, Martin Puhr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2013
Characterization and clinical relevance of ALDHbright populations in prostate cancerClémentine Le Magnen, Lukas Bubendorf, Cyrill A Rentsch, et al.
The Journal of Pathology|February 28, 2018
Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event and FKBP4 as a potential driver of castration resistanceJoël R Federer-Gsponer, Cristina Quintavalle, David C Müller, et al.
European Urology Oncology|December 13, 2021
Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin ImmunotherapyJack V W Bacon, David C Müller, Elie Ritch, et al.
Oncotarget|December 16, 2016
MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signalingAnne Offermann, Ignacija Vlasic, Isabella Syring, et al.
British Journal of Cancer|April 17, 2019
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)Alessandra Curioni-Fontecedro, Jean Yannis Perentes, Hans Gelpke, et al.
Pageof 27